A type of immune cell that calms down inflammation (Tregs) doesn’t help kill the Pneumocystis fungus, but it does stop the lungs from getting too damaged — like a brake on the immune system’s...
Claim Context
Regulatory T cells (Tregs) modulate lung inflammation during Pneumocystis pneumonia in mice without affecting fungal clearance, as depletion of Tregs or IL-10 increases inflammation but not fungal burden, and adoptive transfer of Tregs reduces inflammation without altering pathogen load.
“In rodent models, faster fungal clearance and heightened inflammation occur when IL‐10 or Tregs are depleted... The adoptive transfer of CD25 + CD4 + T cells to infected SCID mice alleviates inflammation without affecting the fungal load.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether enhancing Treg activity reduces inflammation without compromising fungal clearance in human PCP.
A double-blind RCT of 80 immunocompromised patients with PCP, randomized to receive low-dose IL-2 (to expand Tregs) or placebo, with primary outcomes: BAL inflammatory cytokines (IL-6, TNF-α) and fungal burden (qPCR) at day 7.
Whether Treg frequency in BAL fluid correlates with inflammation severity but not fungal burden in human PCP.
A prospective cohort of 100 immunocompromised patients with PCP, measuring Treg frequency (CD4+CD25+FOXP3+) and IL-10 levels in BAL fluid at diagnosis and day 7, correlating with clinical inflammation scores and fungal burden.
Whether patients with IPEX syndrome (FOXP3 mutations) have higher rates of PCP and more severe inflammation than other immunodeficiencies.
A matched case-control study of 30 IPEX patients with PCP and 60 other immunodeficient patients with PCP, comparing inflammatory markers, lung injury scores, and fungal burden.
Whether Treg frequency is higher in patients with PCP compared to those with other pneumonias.
A cross-sectional analysis of BAL fluid from 80 patients: 30 with PCP, 25 with bacterial pneumonia, 25 with viral pneumonia, measuring Treg frequency and inflammatory cytokines.
Clinical presentation of PCP in patients with FOXP3 mutations.
A case series of 5 patients with IPEX syndrome who develop PCP, documenting Treg levels, inflammation markers, and response to immunosuppression.